Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
725 CHF | -0.68% | -0.68% | +43.56% |
Sales 2024 * | 42.98B 38.76B 3,373B | Sales 2025 * | 52.62B 47.46B 4,130B | Capitalization | 739B 666B 57,973B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B 10.76B 937B | Net income 2025 * | 16.55B 14.93B 1,299B | EV / Sales 2024 * | 17.6 x |
Net Debt 2024 * | 18.07B 16.3B 1,418B | Net Debt 2025 * | 15B 13.53B 1,177B | EV / Sales 2025 * | 14.3 x |
P/E ratio 2024 * |
61.4
x | P/E ratio 2025 * |
44.2
x | Employees | 43,000 |
Yield 2024 * |
0.63% | Yield 2025 * |
0.73% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 week | -0.68% | ||
1 month | +5.07% | ||
3 months | +9.85% | ||
6 months | +35.51% | ||
Current year | +43.56% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 31/12/95 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 31/12/00 |
Ruth Gimeno
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 24/01/21 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 31/03/09 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 31/12/04 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 725 | -.--% | 0 |
30/05/24 | 725 | -.--% | 0 |
29/05/24 | 725 | -.--% | 0 |
28/05/24 | 725 | -0.68% | 25 |
27/05/24 | 730 | -.--% | 0 |
Delayed Quote Swiss Exchange, May 28, 2024 at 04:31 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B | |
-.--% | 122B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock